Professor Moein Moghimi, Co-Founder of SMDG and Professor of Pharmaceutics and Nanomedicine is an invited Speaker at the Blood-Brain Barrier Summit a meeting dedicated to Helping to enhance Drug Delivery Across the BBB and to Enable Effective Treatments for Neurodegenerative Diseases